BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Viyash Scientific Ltd. Share Price

NSE
BSE

NSE : VIYASH

BSE : 512529

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹248.25

High

₹259.20

Price Summary

Previous Close ₹255.25
Day's Range ₹248.25 - ₹259.20
Open ₹249.85
52 Week Range ₹166.00 - ₹277.35
Volume 29,49,212
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 7,531.30
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.00
Price/Earning (TTM) 62.88
TTM EPS (₹) 4.06
P/E Ratio 149.64
Book Value(₹) 3.83
PAT Margin (%) 2.02
Face Value (₹) 2.00
ROCE(%) 9.30

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 7723.1 13103.4
Expenses N/A N/A
PBT -366.6 491.7
Operating profit 0.0 0.0
Net profit -321.8 584.9

Shareholding Pattern

Promoters (% Holding)

61.31%

Mutual funds (% Holding)

6.44%

Non-Institution (% Holding)

27.76%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.94%

About Viyash Scientific Ltd.

Founded 1985
Managing Director Rajaram Narayanan
NSE Symbol VIYASH

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,27,933.39 1,787.95 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,75,833.11 6,625.45 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,49,548.89 4,427.50 3,132.70 - 3,132.70
Apollo Hospitals Enterprise Ltd. 1,19,392.31 8,300.00 6,696.50 - 6,696.50
Cipla Ltd. 1,13,154.89 1,400.70 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,09,568.82 1,087.05 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,06,654.01 1,277.80 1,148.40 - 1,148.40
Lupin Ltd. 1,03,704.91 2,265.00 1,836.80 - 1,836.80
Mankind Pharma Ltd. 96,492.75 2,337.90 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 95,090.78 977.05 903.00 - 903.00
no-content No Records Found

Latest News

May
12
2026
EQUITY Posted on May 12th 2026

Viyash Scientific submits analyst meet intimation

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Viyash Scientific has informed that the Company has scheduled a conference call with the Analysts/Investors on Wednesday, May 20, 2026, at 4.00 pm (IST) to discuss its Q4FY26 financial results. The Conference call details are enclosed. The above details are also available on the website of the Company in the Investors Section at: www.viyash.com
The above information is a part of company’s filings submitted to BSE.
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Viyash Scientific informs about board meeting

Viyash Scientific has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 19, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026; recommend dividend, if any, on the equity shares of the Company for the year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
22
2026
EQUITY Posted on Apr 22nd 2026

Viyash Scientific informs about outcome of board meeting

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Viyash Scientific has informed that the Board of Directors of the Company, at its meeting held today: (a) Approved the appointment of Amit Jain (DIN: 06917608) as an Additional Director (Non-Executive, Non-Independent) of the Company; (b) Approved the appointment of Abhiroop Jayanthi (DIN: 10354445) as an Additional Director (Non- Executive, Non-Independent) of the Company; and (c) Approved revised ESOP Pool Viyash Scientific Limited Employee Stock Option Scheme 2026 (ESOP 2026).
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
20
2026
EQUITY Posted on Apr 20th 2026

Viyash Scientific informs about change in domain name of website

Viyash Scientific has informed that in pursuance of the provisions of Regulation 30, 46 and other applicable regulations, if any, of the SEBI Listing Regulations, 2015, the domain name of the website of the Company has been changed from www.sequent.in to www.viyash.com with immediate effect. Also noted that pursuant to Regulation 30(5) of the SEBI Listing Regulations, the email id of the Directors/Key Managerial Personnel who are authorized to determine materiality of event/information for the purpose of making disclosures to the stock exchange(s) has also been changed consequent upon change in the domain name i.e. from investorrelations@sequent.in to investorrelations@viyash.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
6
2026
EQUITY Posted on Jun 6th 2026

Zim Laboratories informs about newspaper advertisements

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zim Laboratories has submitted a copy of newspaper advertisements published in respect of 42nd Annual General Meeting of the Company scheduled to be held on Monday, 29th June, 2026 in the Newspapers, The Financial Express (English) all India Edition, Indian Express (English) Nagpur Edition and Loksatta (Marathi).

The above information is a part of company’s filings submitted to BSE.  

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Viyash Scientific Ltd. ?

The current share price of Viyash Scientific Ltd. is ₹255.25 as of 2026-06-05.

The market capitalisation of Viyash Scientific Ltd. is ₹11,146.88 as of 2026-06-05.

The 1-year return of Viyash Scientific Ltd. is 0.00% as of 2026-06-05.

The P/E ratio of Viyash Scientific Ltd. is 149.64 as of 2026-06-07.

The 52-week high and low of Viyash Scientific Ltd. are ₹277.35 and ₹166.00, respectively, as of 2026-06-05.

The dividend yield of Viyash Scientific Ltd. is 0.0% as of2026-06-05.

You can buy Viyash Scientific Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Viyash Scientific Ltd. is Rajaram Narayanan.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore